Neovasc Announces Treatment of First Patient in TIARA-I Clinical Trial
VANCOUVER, Dec. 1, 2014 /CNW/ – Neovasc Inc. (“Neovasc” or the “Company“) (NASDAQ: NVCN) (TSX: NVC) today announced that the first patient has been enrolled in the European arm of its TIARA-I Early Feasibility Trial, a...